EGFR and non-small cell lung carcinoma: Gefitinib’s antitumor activity in the xenografted NSCLC cell lines and mouse model was enhanced by curcumin, which suppressed NSCLC proliferation, EGFR phosphorylation, EGFR ubiquitination, and induced apoptosis [299].